McKesson Corporation (MCK) key performance indicators and operating metrics (96 metrics) from SEC EDGAR filings, earnings calls, and investor decks. First-party data.
| Metric | Latest Value | Period |
|---|---|---|
| Medical-Surgical Solutions segment revenue | 2.87B | FY2026-Q4 |
| Prescription technology solutions revenue | 1.5B | FY2026-Q4 |
| Medical-Surgical Solutions revenues (Q4) | 2.9B | FY2026-Q4 |
| Prescription Technology Solutions revenues (Q4) | 1.5B | FY2026-Q4 |
| Operating Profit | 1.76B | FY2026-Q4 |
| Earnings | 1.43B | FY2026-Q4 |
| Earnings per Diluted Share | 11.69 USD_per_share | FY2026-Q4 |
| Medical-Surgical Solutions adjusted segment operating profit | 271M | FY2026-Q4 |
| Medical-Surgical Solutions adjusted segment operating profit (Q4) | 271M | FY2026-Q4 |
| Medical-Surgical Solutions Adjusted Segment Operating Profit Margin | 9.45 percent | FY2026-Q4 |
| Medical-Surgical Solutions Segment Operating Profit (Q4) | 232M | FY2026-Q4 |
| Prescription Technology Solutions adjusted segment operating profit | 322M | FY2026-Q4 |
| Prescription Technology Solutions adjusted segment operating profit (Q4) | 322M | FY2026-Q4 |
| Prescription Technology Solutions Adjusted Segment Operating Profit Margin | 21.54 percent | FY2026-Q4 |
Back to MCK overview · MCK earnings · MCK holders
Data sourced from U.S. SEC EDGAR filings, earnings call transcripts, and investor decks. Not personalized investment advice.